Olivia Ifeoma Okereke, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Depression | 55 | 2024 | 7766 | 3.900 |
Why?
|
Depressive Disorder | 16 | 2021 | 3748 | 2.400 |
Why?
|
Fatty Acids, Omega-3 | 7 | 2023 | 1344 | 2.270 |
Why?
|
Aging | 24 | 2023 | 8663 | 2.010 |
Why?
|
Cognition Disorders | 24 | 2018 | 4043 | 2.010 |
Why?
|
Cognition | 31 | 2024 | 6770 | 2.000 |
Why?
|
Cacao | 2 | 2024 | 98 | 1.750 |
Why?
|
Cholecalciferol | 6 | 2024 | 535 | 1.680 |
Why?
|
Phobic Disorders | 6 | 2018 | 439 | 1.640 |
Why?
|
Telomere | 5 | 2021 | 910 | 1.500 |
Why?
|
C-Peptide | 6 | 2012 | 419 | 1.470 |
Why?
|
Vitamins | 8 | 2024 | 1623 | 1.420 |
Why?
|
Caregivers | 5 | 2022 | 2095 | 1.350 |
Why?
|
Affect | 3 | 2021 | 1475 | 0.970 |
Why?
|
Leukocytes | 3 | 2018 | 2045 | 0.890 |
Why?
|
Vitamin D | 7 | 2023 | 3224 | 0.880 |
Why?
|
Alzheimer Disease | 11 | 2023 | 8038 | 0.860 |
Why?
|
Apolipoprotein E4 | 3 | 2024 | 668 | 0.830 |
Why?
|
Aged | 90 | 2024 | 163284 | 0.820 |
Why?
|
Dietary Supplements | 12 | 2024 | 3296 | 0.810 |
Why?
|
DNA Copy Number Variations | 2 | 2020 | 1941 | 0.770 |
Why?
|
Nurses | 16 | 2022 | 2462 | 0.720 |
Why?
|
Vitamin D Deficiency | 4 | 2020 | 1343 | 0.710 |
Why?
|
Neuropsychological Tests | 15 | 2024 | 6994 | 0.660 |
Why?
|
Double-Blind Method | 10 | 2024 | 12025 | 0.630 |
Why?
|
DNA, Mitochondrial | 2 | 2020 | 817 | 0.630 |
Why?
|
Depressive Disorder, Major | 4 | 2023 | 4644 | 0.600 |
Why?
|
DNA Methylation | 2 | 2023 | 4287 | 0.580 |
Why?
|
Amyloid beta-Peptides | 6 | 2015 | 3587 | 0.570 |
Why?
|
Mental Health | 7 | 2023 | 3014 | 0.550 |
Why?
|
Humans | 148 | 2024 | 744376 | 0.550 |
Why?
|
Antidepressive Agents | 14 | 2020 | 2838 | 0.550 |
Why?
|
Middle Aged | 85 | 2024 | 213388 | 0.530 |
Why?
|
Memory | 10 | 2019 | 2174 | 0.520 |
Why?
|
Life Style | 6 | 2021 | 3835 | 0.520 |
Why?
|
Female | 107 | 2024 | 380200 | 0.510 |
Why?
|
Cross-Sectional Studies | 19 | 2024 | 25041 | 0.500 |
Why?
|
Bereavement | 1 | 2018 | 278 | 0.470 |
Why?
|
Vitamin B 6 | 1 | 2015 | 237 | 0.460 |
Why?
|
Seafood | 2 | 2014 | 384 | 0.450 |
Why?
|
Anxiety | 7 | 2021 | 4296 | 0.450 |
Why?
|
Flavonoids | 1 | 2016 | 443 | 0.450 |
Why?
|
Prospective Studies | 45 | 2023 | 53291 | 0.440 |
Why?
|
Primary Prevention | 2 | 2020 | 1167 | 0.440 |
Why?
|
Patient Preference | 1 | 2020 | 889 | 0.430 |
Why?
|
Vitamin B 12 | 1 | 2015 | 527 | 0.400 |
Why?
|
Dementia | 5 | 2023 | 2518 | 0.400 |
Why?
|
Neoplasms, Glandular and Epithelial | 4 | 2016 | 484 | 0.400 |
Why?
|
Psychiatry | 1 | 2024 | 1695 | 0.390 |
Why?
|
Mental Health Services | 2 | 2022 | 1643 | 0.390 |
Why?
|
Psychiatric Status Rating Scales | 6 | 2020 | 6038 | 0.380 |
Why?
|
Healthcare Disparities | 3 | 2022 | 3154 | 0.380 |
Why?
|
Multifactorial Inheritance | 1 | 2018 | 1194 | 0.380 |
Why?
|
Interviews as Topic | 4 | 2013 | 2539 | 0.370 |
Why?
|
Diet, Mediterranean | 3 | 2013 | 700 | 0.370 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3647 | 0.350 |
Why?
|
Mental Disorders | 4 | 2019 | 6600 | 0.350 |
Why?
|
Residence Characteristics | 4 | 2016 | 2050 | 0.340 |
Why?
|
Proportional Hazards Models | 14 | 2022 | 12356 | 0.340 |
Why?
|
Insulin | 5 | 2012 | 6582 | 0.330 |
Why?
|
Social Participation | 2 | 2021 | 173 | 0.330 |
Why?
|
Activities of Daily Living | 4 | 2023 | 2418 | 0.330 |
Why?
|
Health Status | 10 | 2019 | 4033 | 0.320 |
Why?
|
Geriatric Psychiatry | 1 | 2008 | 70 | 0.320 |
Why?
|
Quality of Life | 8 | 2022 | 12803 | 0.320 |
Why?
|
Educational Status | 3 | 2016 | 2540 | 0.310 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2006 | 2015 | 0.310 |
Why?
|
Folic Acid | 1 | 2015 | 1300 | 0.310 |
Why?
|
Risk Factors | 36 | 2022 | 72295 | 0.310 |
Why?
|
Peptide Fragments | 3 | 2012 | 5096 | 0.310 |
Why?
|
Women's Health | 6 | 2017 | 2034 | 0.300 |
Why?
|
Interview, Psychological | 1 | 2011 | 812 | 0.300 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2024 | 9957 | 0.290 |
Why?
|
United States | 33 | 2021 | 69869 | 0.290 |
Why?
|
Weight Gain | 3 | 2014 | 2293 | 0.290 |
Why?
|
Self Report | 6 | 2019 | 3557 | 0.290 |
Why?
|
Dietary Fats | 2 | 2012 | 2016 | 0.280 |
Why?
|
Attention | 4 | 2016 | 2397 | 0.270 |
Why?
|
Longitudinal Studies | 18 | 2022 | 13988 | 0.270 |
Why?
|
Exercise | 9 | 2022 | 5615 | 0.270 |
Why?
|
Male | 47 | 2024 | 350118 | 0.270 |
Why?
|
Patient Compliance | 1 | 2016 | 2685 | 0.270 |
Why?
|
Health Surveys | 7 | 2020 | 4036 | 0.250 |
Why?
|
Cohort Studies | 19 | 2021 | 40558 | 0.250 |
Why?
|
Adult | 46 | 2023 | 214056 | 0.240 |
Why?
|
Peptic Ulcer Perforation | 1 | 2024 | 24 | 0.240 |
Why?
|
Diet | 8 | 2023 | 7937 | 0.240 |
Why?
|
Psychotic Disorders | 1 | 2019 | 3046 | 0.240 |
Why?
|
Alcohol Drinking | 5 | 2020 | 3966 | 0.240 |
Why?
|
Stress, Psychological | 4 | 2020 | 4244 | 0.230 |
Why?
|
Organizations | 1 | 2024 | 170 | 0.220 |
Why?
|
Ovarian Neoplasms | 5 | 2019 | 4839 | 0.220 |
Why?
|
Linear Models | 7 | 2015 | 5952 | 0.220 |
Why?
|
Weight Loss | 1 | 2014 | 2625 | 0.220 |
Why?
|
Suicide | 5 | 2018 | 1474 | 0.210 |
Why?
|
Anxiety Disorders | 2 | 2021 | 2690 | 0.210 |
Why?
|
Minerals | 1 | 2024 | 275 | 0.210 |
Why?
|
Peptic Ulcer | 1 | 2024 | 223 | 0.210 |
Why?
|
Coronary Disease | 1 | 2017 | 6077 | 0.210 |
Why?
|
Comorbidity | 6 | 2020 | 10388 | 0.210 |
Why?
|
Financing, Organized | 1 | 2023 | 202 | 0.200 |
Why?
|
Proxy | 1 | 2022 | 145 | 0.200 |
Why?
|
Executive Function | 2 | 2023 | 1364 | 0.200 |
Why?
|
Task Performance and Analysis | 1 | 2005 | 780 | 0.200 |
Why?
|
Follow-Up Studies | 19 | 2017 | 39052 | 0.190 |
Why?
|
Sunbathing | 1 | 2021 | 60 | 0.190 |
Why?
|
Mothers | 3 | 2022 | 2165 | 0.190 |
Why?
|
Apolipoproteins E | 2 | 2024 | 1438 | 0.190 |
Why?
|
Skin Pigmentation | 1 | 2022 | 282 | 0.180 |
Why?
|
Reproducibility of Results | 8 | 2019 | 19905 | 0.180 |
Why?
|
Incidence | 12 | 2020 | 20950 | 0.180 |
Why?
|
Ownership | 1 | 2022 | 332 | 0.180 |
Why?
|
Marital Status | 2 | 2019 | 437 | 0.180 |
Why?
|
Aged, 80 and over | 17 | 2021 | 57776 | 0.180 |
Why?
|
Logistic Models | 7 | 2019 | 13409 | 0.170 |
Why?
|
Circadian Rhythm | 2 | 2024 | 2624 | 0.170 |
Why?
|
Calcifediol | 1 | 2020 | 166 | 0.170 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2023 | 604 | 0.170 |
Why?
|
Glaucoma, Open-Angle | 2 | 2016 | 706 | 0.170 |
Why?
|
Glutens | 1 | 2021 | 230 | 0.170 |
Why?
|
Diet, Vegetarian | 1 | 2020 | 174 | 0.160 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15520 | 0.160 |
Why?
|
Risk | 9 | 2019 | 9688 | 0.160 |
Why?
|
Adult Children | 1 | 2019 | 100 | 0.160 |
Why?
|
Chronobiology Disorders | 1 | 2019 | 74 | 0.160 |
Why?
|
Body Mass Index | 9 | 2014 | 12720 | 0.160 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12244 | 0.150 |
Why?
|
Photoperiod | 1 | 2018 | 137 | 0.150 |
Why?
|
Caffeine | 2 | 2013 | 699 | 0.150 |
Why?
|
Coffee | 2 | 2013 | 578 | 0.150 |
Why?
|
Pilot Projects | 2 | 2023 | 8319 | 0.150 |
Why?
|
Interferon-alpha | 1 | 2002 | 895 | 0.150 |
Why?
|
Fasting | 4 | 2019 | 1592 | 0.150 |
Why?
|
Time Factors | 9 | 2022 | 40077 | 0.150 |
Why?
|
Carotenoids | 1 | 2020 | 624 | 0.150 |
Why?
|
Cost of Illness | 2 | 2020 | 1860 | 0.140 |
Why?
|
Social Isolation | 1 | 2019 | 365 | 0.140 |
Why?
|
Health Status Disparities | 2 | 2020 | 1796 | 0.140 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17445 | 0.140 |
Why?
|
Motor Activity | 4 | 2015 | 2715 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 6 | 2016 | 11725 | 0.140 |
Why?
|
Genetic Markers | 1 | 2023 | 2634 | 0.140 |
Why?
|
Antihypertensive Agents | 2 | 2016 | 2047 | 0.140 |
Why?
|
Smoking | 6 | 2017 | 8987 | 0.140 |
Why?
|
Environmental Exposure | 3 | 2017 | 4232 | 0.140 |
Why?
|
Psychology | 1 | 2018 | 356 | 0.140 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15159 | 0.130 |
Why?
|
Treatment Failure | 1 | 2021 | 2618 | 0.130 |
Why?
|
Morbidity | 2 | 2019 | 1768 | 0.130 |
Why?
|
Grief | 1 | 2018 | 248 | 0.130 |
Why?
|
Diabetes Mellitus | 4 | 2008 | 5749 | 0.130 |
Why?
|
Fruit | 2 | 2018 | 1142 | 0.130 |
Why?
|
Vegetables | 2 | 2018 | 1182 | 0.130 |
Why?
|
Insurance Claim Review | 1 | 2020 | 720 | 0.130 |
Why?
|
Pharmacogenetics | 1 | 2019 | 674 | 0.130 |
Why?
|
Premenopause | 2 | 2017 | 1033 | 0.130 |
Why?
|
Nuts | 2 | 2014 | 257 | 0.130 |
Why?
|
Aniline Compounds | 2 | 2016 | 986 | 0.120 |
Why?
|
Loneliness | 1 | 2016 | 185 | 0.120 |
Why?
|
Case-Control Studies | 4 | 2020 | 21747 | 0.120 |
Why?
|
Trabeculectomy | 1 | 2016 | 160 | 0.120 |
Why?
|
Retirement | 1 | 2016 | 215 | 0.120 |
Why?
|
Prolactin | 1 | 2016 | 669 | 0.120 |
Why?
|
Physical Endurance | 1 | 2016 | 370 | 0.120 |
Why?
|
Religion | 1 | 2016 | 356 | 0.110 |
Why?
|
Bupropion | 1 | 2015 | 303 | 0.110 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1004 | 0.110 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2014 | 227 | 0.110 |
Why?
|
Environment | 1 | 2019 | 1123 | 0.110 |
Why?
|
Air Pollution | 2 | 2017 | 2286 | 0.110 |
Why?
|
Cross Infection | 1 | 2021 | 1417 | 0.110 |
Why?
|
Health Care Surveys | 1 | 2020 | 2453 | 0.100 |
Why?
|
Thiazoles | 2 | 2016 | 1483 | 0.100 |
Why?
|
Television | 2 | 2013 | 409 | 0.100 |
Why?
|
Paternal Age | 1 | 2012 | 84 | 0.100 |
Why?
|
Skin Neoplasms | 2 | 2021 | 5692 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2009 | 3873 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 357 | 0.100 |
Why?
|
Gonadal Steroid Hormones | 1 | 2016 | 711 | 0.100 |
Why?
|
Least-Squares Analysis | 1 | 2012 | 379 | 0.100 |
Why?
|
Genotype | 3 | 2024 | 12952 | 0.100 |
Why?
|
Reference Values | 2 | 2010 | 4982 | 0.100 |
Why?
|
Age of Onset | 3 | 2017 | 3270 | 0.100 |
Why?
|
Odds Ratio | 6 | 2022 | 9849 | 0.100 |
Why?
|
Cognitive Reserve | 1 | 2011 | 76 | 0.090 |
Why?
|
Psychotherapy | 1 | 2020 | 1643 | 0.090 |
Why?
|
Women | 1 | 2012 | 230 | 0.090 |
Why?
|
Postmenopause | 2 | 2017 | 2460 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 21693 | 0.090 |
Why?
|
Amyloidosis | 1 | 2016 | 796 | 0.090 |
Why?
|
Models, Statistical | 2 | 2015 | 5101 | 0.090 |
Why?
|
Eating | 2 | 2014 | 1536 | 0.090 |
Why?
|
Radioimmunoassay | 1 | 2010 | 919 | 0.090 |
Why?
|
Statistics as Topic | 3 | 2016 | 2373 | 0.090 |
Why?
|
Urinary Incontinence | 1 | 2014 | 496 | 0.090 |
Why?
|
Restless Legs Syndrome | 1 | 2012 | 228 | 0.090 |
Why?
|
Memory, Short-Term | 1 | 2015 | 977 | 0.080 |
Why?
|
Edetic Acid | 1 | 2009 | 275 | 0.080 |
Why?
|
Decision Making | 1 | 2022 | 3888 | 0.080 |
Why?
|
Prevalence | 5 | 2016 | 15221 | 0.080 |
Why?
|
Disease Progression | 3 | 2016 | 13285 | 0.080 |
Why?
|
Recurrence | 1 | 2020 | 8340 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2063 | 0.080 |
Why?
|
Area Under Curve | 1 | 2012 | 1655 | 0.080 |
Why?
|
ROC Curve | 2 | 2014 | 3527 | 0.080 |
Why?
|
Psoriasis | 1 | 2015 | 902 | 0.070 |
Why?
|
Income | 1 | 2016 | 1913 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2022 | 3255 | 0.070 |
Why?
|
Delirium | 1 | 2019 | 1610 | 0.070 |
Why?
|
Memory Disorders | 1 | 2014 | 1186 | 0.070 |
Why?
|
Interleukin-6 | 2 | 2014 | 3203 | 0.070 |
Why?
|
Particulate Matter | 2 | 2017 | 2529 | 0.070 |
Why?
|
Research Design | 2 | 2020 | 5986 | 0.070 |
Why?
|
Lead | 1 | 2012 | 852 | 0.070 |
Why?
|
Social Support | 1 | 2016 | 2118 | 0.070 |
Why?
|
Pain | 2 | 2016 | 4987 | 0.070 |
Why?
|
Education | 1 | 2009 | 543 | 0.070 |
Why?
|
Obesity | 3 | 2016 | 12745 | 0.070 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 3020 | 0.070 |
Why?
|
Learning | 1 | 2015 | 1712 | 0.070 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2408 | 0.070 |
Why?
|
Overweight | 2 | 2014 | 2371 | 0.070 |
Why?
|
Pregnancy | 4 | 2020 | 29144 | 0.060 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3778 | 0.060 |
Why?
|
Health Services Accessibility | 1 | 2022 | 5135 | 0.060 |
Why?
|
Sickness Impact Profile | 2 | 2016 | 302 | 0.060 |
Why?
|
Saliva | 2 | 2019 | 809 | 0.060 |
Why?
|
Databases, Factual | 1 | 2020 | 7730 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6489 | 0.060 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 424 | 0.060 |
Why?
|
Melanoma | 1 | 2002 | 5511 | 0.060 |
Why?
|
Positron-Emission Tomography | 2 | 2016 | 6234 | 0.060 |
Why?
|
Telephone | 1 | 2006 | 617 | 0.060 |
Why?
|
Air Pollutants | 1 | 2017 | 2816 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2011 | 1148 | 0.050 |
Why?
|
Vision, Low | 1 | 2005 | 168 | 0.050 |
Why?
|
Sex Distribution | 1 | 2008 | 2297 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2006 | 1591 | 0.050 |
Why?
|
Longevity | 1 | 2010 | 1071 | 0.050 |
Why?
|
Medicare | 1 | 2020 | 6566 | 0.050 |
Why?
|
beta Carotene | 1 | 2023 | 527 | 0.050 |
Why?
|
Biological Clocks | 1 | 2024 | 322 | 0.050 |
Why?
|
Heparin | 1 | 2009 | 1637 | 0.050 |
Why?
|
Laparotomy | 1 | 2024 | 473 | 0.050 |
Why?
|
Academies and Institutes | 1 | 2023 | 317 | 0.050 |
Why?
|
Algorithms | 2 | 2012 | 13882 | 0.050 |
Why?
|
Regression Analysis | 2 | 2013 | 6459 | 0.050 |
Why?
|
Fishes | 2 | 2014 | 569 | 0.050 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5709 | 0.050 |
Why?
|
Adiposity | 1 | 2009 | 1806 | 0.040 |
Why?
|
Divorce | 1 | 2019 | 79 | 0.040 |
Why?
|
Widowhood | 1 | 2019 | 54 | 0.040 |
Why?
|
alpha-Amylases | 1 | 2019 | 41 | 0.040 |
Why?
|
Hostility | 1 | 2020 | 189 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2012 | 15078 | 0.040 |
Why?
|
Inflammation | 2 | 2023 | 10636 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12262 | 0.040 |
Why?
|
Survivors | 1 | 2009 | 2291 | 0.040 |
Why?
|
Hypertension | 2 | 2016 | 8479 | 0.040 |
Why?
|
Nutritional Status | 2 | 2020 | 1609 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3912 | 0.040 |
Why?
|
Intergenerational Relations | 1 | 2019 | 68 | 0.040 |
Why?
|
Stroke | 2 | 2011 | 9981 | 0.040 |
Why?
|
Animals | 7 | 2024 | 168770 | 0.040 |
Why?
|
Mentors | 1 | 2023 | 631 | 0.040 |
Why?
|
Fish Oils | 1 | 2021 | 470 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14723 | 0.040 |
Why?
|
Psychological Tests | 2 | 2012 | 651 | 0.040 |
Why?
|
Mental Recall | 2 | 2014 | 1206 | 0.040 |
Why?
|
Nails | 1 | 2019 | 292 | 0.040 |
Why?
|
Brain Ischemia | 1 | 2011 | 3265 | 0.040 |
Why?
|
Infusions, Intravenous | 1 | 2002 | 2274 | 0.040 |
Why?
|
Electroconvulsive Therapy | 1 | 2002 | 477 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2015 | 5321 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2013 | 2971 | 0.040 |
Why?
|
Walking | 1 | 2024 | 1180 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2021 | 1060 | 0.030 |
Why?
|
Young Adult | 5 | 2022 | 56434 | 0.030 |
Why?
|
Hair | 1 | 2019 | 481 | 0.030 |
Why?
|
Trabecular Meshwork | 1 | 2016 | 99 | 0.030 |
Why?
|
Pregnancy Trimester, Second | 1 | 2018 | 732 | 0.030 |
Why?
|
Tonometry, Ocular | 1 | 2016 | 237 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 857 | 0.030 |
Why?
|
Angina, Unstable | 1 | 2019 | 926 | 0.030 |
Why?
|
Ozone | 1 | 2017 | 469 | 0.030 |
Why?
|
Diagnostic Self Evaluation | 1 | 2015 | 230 | 0.030 |
Why?
|
Anticoagulants | 1 | 2009 | 4600 | 0.030 |
Why?
|
Parietal Lobe | 1 | 1998 | 838 | 0.030 |
Why?
|
Adolescent | 4 | 2024 | 85784 | 0.030 |
Why?
|
Feces | 1 | 2019 | 1401 | 0.030 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 676 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2355 | 0.030 |
Why?
|
Meat Products | 1 | 2013 | 99 | 0.030 |
Why?
|
Health Behavior | 2 | 2017 | 2635 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2002 | 6621 | 0.030 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7785 | 0.030 |
Why?
|
Databases, Bibliographic | 1 | 2012 | 128 | 0.030 |
Why?
|
Drug Utilization Review | 1 | 2013 | 245 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2015 | 940 | 0.030 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 2012 | 144 | 0.020 |
Why?
|
Maternal Exposure | 1 | 2018 | 961 | 0.020 |
Why?
|
Verbal Learning | 1 | 2014 | 468 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2018 | 63115 | 0.020 |
Why?
|
Phenotype | 1 | 2009 | 16367 | 0.020 |
Why?
|
Hydrocortisone | 1 | 2019 | 1826 | 0.020 |
Why?
|
Outpatients | 1 | 2019 | 1487 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2016 | 1184 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2024 | 3680 | 0.020 |
Why?
|
Length of Stay | 1 | 2024 | 6311 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2017 | 20823 | 0.020 |
Why?
|
Age Factors | 2 | 2021 | 18373 | 0.020 |
Why?
|
Mother-Child Relations | 1 | 2014 | 481 | 0.020 |
Why?
|
Intraocular Pressure | 1 | 2016 | 1270 | 0.020 |
Why?
|
Health Occupations | 1 | 2011 | 224 | 0.020 |
Why?
|
Meat | 1 | 2013 | 592 | 0.020 |
Why?
|
Developed Countries | 1 | 2012 | 437 | 0.020 |
Why?
|
Laser Therapy | 1 | 2016 | 1072 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2795 | 0.020 |
Why?
|
Cerebrovascular Circulation | 1 | 1998 | 2732 | 0.020 |
Why?
|
Sleep | 1 | 2024 | 4623 | 0.020 |
Why?
|
Hospitals | 1 | 2021 | 3954 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15535 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1372 | 0.020 |
Why?
|
Preventive Health Services | 1 | 2012 | 575 | 0.020 |
Why?
|
Chronic Disease | 2 | 2013 | 9145 | 0.020 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2015 | 2016 | 0.020 |
Why?
|
Parents | 1 | 2020 | 3405 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2009 | 546 | 0.020 |
Why?
|
Estrogen Replacement Therapy | 1 | 2012 | 1203 | 0.020 |
Why?
|
Population Surveillance | 1 | 2016 | 2616 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1888 | 0.020 |
Why?
|
Massachusetts | 1 | 2017 | 8662 | 0.020 |
Why?
|
Vitamin E | 1 | 2009 | 869 | 0.020 |
Why?
|
Menopause | 1 | 2012 | 1626 | 0.010 |
Why?
|
Alcoholism | 1 | 2014 | 1906 | 0.010 |
Why?
|
Child | 2 | 2022 | 77708 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6896 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Hippocampus | 1 | 2015 | 3675 | 0.010 |
Why?
|
Sex Factors | 1 | 2016 | 10400 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2005 | 11126 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4424 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8386 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2024 | 77459 | 0.010 |
Why?
|
Bone and Bones | 1 | 2012 | 2576 | 0.010 |
Why?
|
Fatty Acids | 1 | 2009 | 1809 | 0.010 |
Why?
|
Blood Pressure | 1 | 2016 | 8551 | 0.010 |
Why?
|
Mortality | 1 | 2011 | 2864 | 0.010 |
Why?
|
Developing Countries | 1 | 2012 | 2815 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 25628 | 0.010 |
Why?
|
Public Health | 1 | 2012 | 2602 | 0.010 |
Why?
|
Energy Metabolism | 1 | 2010 | 2897 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9584 | 0.010 |
Why?
|
Infant | 1 | 2019 | 35134 | 0.010 |
Why?
|
Survival Analysis | 1 | 2009 | 10252 | 0.010 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1998 | 1107 | 0.010 |
Why?
|
Risk Assessment | 1 | 2012 | 23336 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1998 | 6366 | 0.010 |
Why?
|
Mice | 1 | 2016 | 81202 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35424 | 0.000 |
Why?
|
Alleles | 1 | 1998 | 6933 | 0.000 |
Why?
|
Brain Mapping | 1 | 1998 | 6670 | 0.000 |
Why?
|